Prevention and Mitigation of Experimental Autoimmune Encephalomyelitis by Murine β-Defensins via Induction of Regulatory T Cells.
The antimicrobial peptide murine β-defensin-14 (mBD14) was found to exert in addition to its antimicrobial activity the capacity to induce regulatory T cells (Treg) as demonstrated in the model of contact hypersensitivity. Since it is induced by UV radiation (UVR), mBD14 may contribute to the antigen-specific immunosuppression by UVR. To prove whether this applies also for other immunologic models and due to the fact that UVR appears to have beneficial effects on multiple sclerosis, we utilized the model of experimental autoimmune encephalomyelitis (EAE). Injection of mBD14 into mice before immunization with myelin oligodendrocyte glycoprotein caused amelioration of the disease with less central nervous system inflammation, decreased levels of pro-inflammatory cytokines and cytotoxic T cells. The beneficial effect was due to Foxp3+ Treg since it was lost upon in vivo depletion of Treg. mBD14, however, also acts in a therapeutic setting, since injection of mBD14 into mice with clinical features of EAE reduced the clinical score significantly. Human β-defensin-3, the human orthologue of mBD14, induced in vitro Treg-specific markers in CD4+CD25- T cells, shifting these non-regulatory cells into a regulatory phenotype with suppressive features. Thus, defensins may represent candidates worth being further pursued for the therapy of multiple sclerosis.Journal of Investigative Dermatology accepted article preview online, 13 October 2015. doi:10.1038/jid.2015.405.